Jentadueto XR
Jentadueto XR

1.9
Used to address diabetes, this generic medicine modulates insulin distribution and suppresses hepatic glucose production.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Linagliptin, Metformin hydrochloride
Reference Brand
Linagliptin, metformin
Product Origin
Generic Brand
Product Manufacturer
Boehringer Ingelheim
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
DPP-4 Inhibitor, Biguanide Combination
Pharmacological Class
Antidiabetic Combination
Clinical Indications
Manufacturer Description
Developed to mitigate elevated blood glucose to support long-term metabolic health and target insulin receptor action.
Mechanism of Action
Metformin lowers liver glucose output while linagliptin increases active inkretin hormones to optimize insulin output.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe renal impairment, Acute metabolic acidosis, Diabetic ketoacidosis
Severe Adverse Events
Lactic acidosis — requires immediate medical attention, Acute pancreatitis — requires immediate medical attention
Common Side Effects
Diarrhea, Nausea, Headache
Uncommon Side Effects
Stuffy nose, Metallic taste, Flatulence
Drug Interactions
Contrast Media, Alcohol, Rifampin
Pregnancy Safety Warnings
TGA Category C: Use if benefit outweighs risk. Avoid in late term. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Jentadueto XR is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Allergy Relief Australia - Buy Hydroxyzine Australia